I was looking into the upcoming Hilton IPO and stumbled across this little company. They are slated to IPO on December 12th, and are priced at $6-$8 per share. Why is this interesting? This company, and I think it will be the first, is making biologics to treat dogs, cats, and horses. One of the first on their list is a TNFR for dogs. Basically the canine version of Humira or Enbrel. What is really impressive is the executive team they have pulled together to form the core of this company. They have a web site so you can read more about them there. Ticker will be KIN. I think they are going to fill a completely unmet need.
Have you looked at ADXS? They have a HER2 directed bacterial vaccine for dogs (and HPV vaccines for ovarian cancers in humans, the lesser animal). Amazing how many billions are spent on pets just in the US alone.
ADSX Appllied Digital Soloutions went out of business over 2 years ago and became Digital Angel (DIGA) who lost everything and is now Verichip. They market implantable chips for pets. They have no such products or vaccines that I know of.